APA (7th ed.) Citation

Perard, R., Samyshkin, Y., & Guillermin, A. (2011). PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK. Value in Health, A450. https://doi.org/10.1016/j.jval.2011.08.1188

Chicago Style (17th ed.) Citation

Perard, R., Y. Samyshkin, and A.L.G Guillermin. "PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK." Value in Health 2011: A450. https://doi.org/10.1016/j.jval.2011.08.1188.

MLA (9th ed.) Citation

Perard, R., et al. "PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK." Value in Health, 2011, p. A450, https://doi.org/10.1016/j.jval.2011.08.1188.